144 related articles for article (PubMed ID: 34360986)
21. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
22. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus.
Harnois MJ; Dennis M; Stöhr D; Valencia SM; Rodgers N; Semmes EC; Webster HS; Jenks JA; Barfield R; Pollara J; Chan C; Sinzger C; Permar SR
J Infect Dis; 2022 Nov; 226(9):1667-1677. PubMed ID: 35970817
[TBL] [Abstract][Full Text] [Related]
24. Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
Popescu I; Mannem H; Winters SA; Hoji A; Silveira F; McNally E; Pipeling MR; Lendermon EA; Morrell MR; Pilewski JM; Hanumanthu VS; Zhang Y; Gulati S; Shah PD; Iasella CJ; Ensor CR; Armanios M; McDyer JF
Am J Respir Crit Care Med; 2019 Feb; 199(3):362-376. PubMed ID: 30088779
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
[TBL] [Abstract][Full Text] [Related]
26. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
27. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis.
Solidoro P; Patrucco F; Libertucci D; Verri G; Sidoti F; Curtoni A; Boffini M; Simonato E; Rinaldi M; Cavallo R; Costa C
Ther Adv Respir Dis; 2019; 13():1753466619878555. PubMed ID: 31566097
[TBL] [Abstract][Full Text] [Related]
28. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.
Lilleri D; Gerna G; Fornara C; Lozza L; Maccario R; Locatelli F
Blood; 2006 Aug; 108(4):1406-12. PubMed ID: 16614242
[TBL] [Abstract][Full Text] [Related]
29. Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.
Semmes EC; Miller IG; Wimberly CE; Phan CT; Jenks JA; Harnois MJ; Berendam SJ; Webster H; Hurst JH; Kurtzberg J; Fouda GG; Walsh KM; Permar SR
J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35763348
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
[TBL] [Abstract][Full Text] [Related]
31. NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation.
Vietzen H; Pollak K; Honsig C; Jaksch P; Puchhammer-Stöckl E
J Infect Dis; 2018 Feb; 217(5):802-806. PubMed ID: 29220498
[TBL] [Abstract][Full Text] [Related]
32. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.
Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G
J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078
[TBL] [Abstract][Full Text] [Related]
33. beta-Herpesvirus (human cytomegalovirus and human herpesvirus 6) reactivation in at-risk lung transplant recipients and in human immunodeficiency virus-infected patients.
Michaelides A; Glare EM; Spelman DW; Wesselingh SL; Hoy JF; Mijch AM; Kotsimbos TC
J Infect Dis; 2002 Jul; 186(2):173-80. PubMed ID: 12134252
[TBL] [Abstract][Full Text] [Related]
34. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
35. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea.
La Y; Kwon DE; Yoo SG; Lee KH; Han SH; Song YG
BMC Infect Dis; 2019 Nov; 19(1):948. PubMed ID: 31703564
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
[TBL] [Abstract][Full Text] [Related]
37. Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients.
Gerna G; Lilleri D; Rognoni V; Agozzino M; Meloni F; Oggionni T; Pellegrini C; Arbustini E; D'Armini AM
Am J Transplant; 2009 May; 9(5):1142-50. PubMed ID: 19422339
[TBL] [Abstract][Full Text] [Related]
38. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
40. Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection.
Adhikari A; Eltahla A; Lloyd AR; Rodrigo C; Agapiou D; Bull RA; Tedla N
J Immunol Methods; 2021 Aug; 495():113087. PubMed ID: 34147479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
